Guardant Health
GH
#2613
Rank
โ‚น458.45 B
Marketcap
โ‚น3,711
Share price
-9.56%
Change (1 day)
97.43%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: โ‚น458.45 Billion

As of February 2025 Guardant Health has a market cap of โ‚น458.45 Billion. This makes Guardant Health the world's 2613th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น458.45 B42.09%
2024โ‚น322.64 B18.04%
2023โ‚น273.33 B18.55%
2022โ‚น230.56 B-69.53%
2021โ‚น756.79 B-19.69%
2020โ‚น942.29 B80.08%
2019โ‚น523.26 B132.16%
2018โ‚น225.39 B

End of Day market cap according to different sources

On Feb 21st, 2025 the market cap of Guardant Health was reported to be:

โ‚น458.45 Billion
by Nasdaq info icon info icon
โ‚น458.45 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น1.854 T 304.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น188.52 B-58.88%๐Ÿ‡บ๐Ÿ‡ธ USA